Include All CSL Behring Country Sites
About CSL Behring
Quality & Safety
CSL Research & Development
> CSL Behring - UK Homepage
For Healthcare Professionals
CSL Behring is committed to improving the quality of life for patients with rare and serious diseases. The company develops, manufactures and markets a range of products including:
For rapid warfarin reversal, von Willebrand disease, haemophilia and congenital fibrinogen deficiency
For hereditary angioedema, immune deficiency disorders, and haemolytic disease of the newborn
Resource centre for healthcare professionals
Rapid warfarin reversal
Von Willebrand Disease
Congenital Fibrinogen Deficiency
Immune Deficiency Disorders
Haemolytic Disease of the Newborn
CSL Behring announced today that the European Commission has ...
As part of its ongoing commitment to the global coagulation ...
CSL Behring has announced that the first patient has been ...
CSL Behring Seeks Proposals for the Third Annual Interlaken ...
Phase II Study Indicates that Fibrinogen Concentrate Given as a ...
CSL Behring Corporate
CSL Plasma USA
CSL Plasma Services Germany
© 2013 CSL Behring